ESPA’s Joint Health Capsules
-
The prevalence of osteoarthritis is one of the most common joint disorder.
-
The prevalence is increasing with an ageing population.
-
Adding joint or connective tissue disorders such as psoriatic arthritis, gout, fibromyalgia and neck or back pain render joint disorders a significant public health problem.
-
Conventional treatment is usually directed to alleviate the principal symptoms, pain and inflammation.
-
Effectiveness is oftenlimited, as evidenced in clinical trials.
-
Since this kind of treatment is sometimes associated with side effects, many patients resort to complementary products such as dietary supplements.
-
Formulated to target underlying pathologies of
-
joint diseases
-
-
Propriety active ingredients
-
Triple mechanisms of action:
*
1. anti – inflammatory
2. regenerative effect
3. immuno-modulation
-
Reduces immune cell tissue infiltration and cytokine expression.
-
Reductions both in swelling and in circulating cytokines in adjuvant-induced arthritis.
-
ESPA’s Joint Health Capsules:
-
Antioxidant activity
-
Cellular activation
-
Extracellular matrix synthesis
-
Anti-inflammatory effect
-
Proteolytic activity reduction
-
Regenerative and healing effect​